C. Touré Kane

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 71 citations

Lamivudine Dual Therapy, Superiority Trial, Protease Inhibitor +9

Travels with HIV: the compliance and health of HIV-infected adults who travel

Carol A. Kemper, Adam Linett, C. Touré Kane et al. · International Journal of STD & AIDS · 1997 · 38 citations

Frequency of Travel of Adults Infected with HIV

Carol A. Kemper, Adam Linett, C. Touré Kane et al. · Journal of Travel Medicine · 1995 · 33 citations

Sexual Health, Infectious Disease Epidemiology, Test Questionnaire +15

Concentrated and linked epidemics of both HSV-2 and HIV-1/HIV-2 infections in Senegal: public health impacts of the spread of HIV

C. Touré Kane, Silman Diawara, Halimatou Diop‐Ndiaye et al. · International Journal of STD & AIDS · 2009 · 31 citations

Virus Epidemiology, Epidemiological Dynamic, Disease Outbreak +20

Terpenoid biosynthesis and the stereochemistry of enzyme-catalysed allylic addition—elimination reactions

David E. Cane, Chris Abell, Paul H. M. Harrison et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 1991 · 27 citations